Ovensa Inc.

Ovensa provides nanomedicine technology platforms, which deliver targeted oral therapy with mucosal and brain-barrier crossing properties. Ovensa focuses on developing personalized treatments for cancer and neurodegenerative diseases and on preventing antibiotic resistance.